Tetraspanin CD9 is required for microparticle release from coated-platelets

Platelets

Volumn 20, Issue 6, 2009, Pages 361-366

  Dale, George L ^a,b   Remenyi, Gyula ^a   Friese, Paul ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

CD9; coated platelet; integrin; microparticle; Platelet

Indexed keywords

ALPHA3BBETA3 INTEGRIN; CD9 ANTIGEN; COLLAGEN; GLYCOPROTEIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY ALB6; MONOCLONAL ANTIBODY AP2; MONOCLONAL ANTIBODY SN4; THROMBIN; UNCLASSIFIED DRUG; ALPHA INTEGRIN; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN;

ARTICLE; DRUG ACTIVITY; IC 50; MEMBRANE FUSION; PLATELET MICROPARTICLE; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; CHEMISTRY; CONFOCAL MICROSCOPY; FLOW CYTOMETRY; HUMAN; IMMUNOLOGY; MEMBRANE MICROPARTICLE; METABOLISM; THROMBOCYTE;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD; BLOOD PLATELETS; CELL-DERIVED MICROPARTICLES; FLOW CYTOMETRY; HUMANS; INTEGRIN ALPHA CHAINS; MEMBRANE GLYCOPROTEINS; MICROSCOPY, CONFOCAL;

EID: 77953639242     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537100903096692     Document Type: Article

References (22)

1. Alberio L, Safa O, Clemetson KJ, Esmon CT, Dale GL. Surface expression and functional characterization of alphagranule factor V in human platelets: Effects of ionophore A23187, thrombin, collagen and convulxin. Blood 2000;95: 1694-1702. (Pubitemid 30120831)
2. Dale GL, Friese P, Batar P, Hamilton SF, Reed GL, Jackson KW, Clemetson KJ, Alberio L. Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface. Nature 2002;415:175-179. (Pubitemid 34059519)
3. Szasz R, Dale GL. COAT-platelets. Current Opinion Hematol 2003;10:351-355.
4. Remenyi G, Szasz R, Friese P, Dale GL. Role of mitochondrial permeability transition pore in coated-platelet formation. Arterioscler Thromb Vasc Biol 2005;25:467-471. (Pubitemid 40189175)
5. Dale GL. Coated-platelets: An emerging component of the procoagulant response. J Thromb Haemostasis 2005;3: 2185-2192. (Pubitemid 41727196)
6. Dale GL, Remenyi G, Friese P. Quantitation of microparticles released from coated-platelets. J Thromb Haemostasis 2005;3:2081-2088. (Pubitemid 43086067)
7. Hemler ME. Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain. Ann Rev Cell Develop Biol 2003;19:397-422. (Pubitemid 37487354)
8. Parise LV, Smyth SS, Coller BS. Platelet morphology, biochemistry and function. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ, Seligsohn U, editors. Williams Hematology, New York: McGraw-Hill; 2001. pp 1357-1408.
9. Clay D, Rubinstein E, Mishal Z, Anjo A, Prenant M, Jasmin C, Boucheix C, Bousse-Kerdiles MC. CD9 and megakaryocyte differentiation. Blood 2001;97:1982-1989. (Pubitemid 32239077)
10. Worthington RE, Carroll RC, Boucheix C. Platelet activation by CD9 monoclonal antibodies is mediated by the Fc gamma II receptor. Br J Haematol 1990;74:216-222. (Pubitemid 20041098)
11. Brisson C, Azorsa DO, Jennings LK, Moog S, Cazenave JP, Lanza F. Co-localization of CD9 and GPIIb-IIIa (alpha IIb beta 3 integrin) on activated platelet pseudopods and alpha-granule membranes. Histochem J 1997;29: 153-165. (Pubitemid 27192190)
12. Mangin PH, Kleitz L, Boucheix C, Gachet C, Lanza F. CD9 negatively regulates integrin alpha(llb)beta(3) activation and could thus prevent excessive platelet recruitment at sites of vascular injury. J Thromb Haemost 2009;7:900-902.
13. Miyado K, Yamada G, Yamada S, Hasuwa H, Nakamura Y, Ryu F, Suzuki K, Kosai K, Inoue K, Ogura A. et al. Requirement of CD9 on the egg plasma membrane for fertilization. Science 2000;287:321-324. (Pubitemid 30046763)
14. Boucheix C, Rubinstein E. Tetraspanins. Cell Mol Life Sci 2001;58:1189-1205. (Pubitemid 32844093)
15. Higginbottom A, Takahashi Y, Bolling L, Coonrod SA, White JM, Partridge LJ, Monk PN. Structural requirements for the inhibitory action of the CD9 large extracellular domain in sperm/oocyte binding and fusion. Biochem Biophys Res Commun 2003;311:208-214. (Pubitemid 37297908)
16. Schmid E, Zurbriggen A, Gassen U, Rima B, ter Meulen V, Schneider-Schaulies J. Antibodies to CD9, a tetraspan transmembrane protein, inhibit canine distemper virusinduced cell-cell fusion but not virus-cell fusion. J Virol 2000;74:7554-7561. (Pubitemid 30613101)
17. Batar P, Dale GL. Simultaneous engagement of thrombin and Fc-gamma-RIIA receptors results in platelets expressing high levels of procoagulant proteins. J Lab Clin Med 2001;138: 393-402. (Pubitemid 34010023)
18. Jobe SM, Leo L, Eastvold JS, Dickneite G, Ratliff TL, Lentz SR, Di PJ. Role of FcR-gamma and factor XIIIA in coated platelet formation. Blood 2005;106:4146-4151. (Pubitemid 41775920)
19. Stipp CS, Kolesnikova TV, Hemler ME. Functional domains in tetraspanin proteins. Trends Biochem Sci 2003;28: 106-112. (Pubitemid 36165140)
20. Hamilton SF, Miller MW, Thompson CA, Dale GL. Glycoprotein IIb/IIIa inhibitors increase COAT-platelet production in vitro. J Lab Clin Med 2004;143:320-326. (Pubitemid 38586497)
21. Tocchetti EV, Flower RL, Lloyd JV. Assessment of in vitrogenerated platelet microparticles using a modified flow cytometric strategy. Thromb Res 2001;103:47-55. (Pubitemid 32588764)
22. Jy W, Horstman JJ, Ahn YS. Forum: Measuring circulating cell-derived microparticles. J Thromb Haemostasis 2004;2: 1842-1851. (Pubitemid 40197488)